Medical Information
Norway
 

Den medisinske informasjonen på dette nettstedet er kun beregnet for helsepersonell i Norge.

Vennligst merk at videre innhold på denne nettsiden vil bli presentert på engelsk.

For å gi deg relevant innhold, trenger vi å vite mer om deg.

Velg kategorien som best beskriver deg.

Informasjonen på dette nettstedet er kun beregnet for helsepersonell i Norge. Vil du fortsette?

Resources Library

Professional Resources

Pfizer.no

The Pfizer company website in Norway provides access to a range of information about the group, news, medicines and Pfizer commitments. This site is intended for patients or caregivers as well as health professionals.

Partner4Better

A Pfizer Medical Information initiative that provides informative topics (such as publication search, adherence, counterfeit medicines, etc) with short video modules to support health care professionals in different aspects of their information search on medicines.

Pfizer Product Pipeline

View Pfizer Pipeline for information about medicines in development.

Medical Information Leaders in Europe (MILE)

MILE (Medical Information Leaders in Europe) is an Industry Association that intends to share knowledge and best practice around the function of Medical Information in Europe. The overall goal is to continuously improve access to information about medicinal products for health care professionals and patients and thereby contribute to a safer and more appropriate use of such products.

Medical Information Gateway

The MI Gateway is an online portal developed by MILE which enables users to easily search for the contact details of the Medical Information function for a specific product.

Felleskatalogen

Felleskatalogen for the general public. Here you can search for prescribing information for different products.

Clinical Trials

Pfizer Clinical Trials

To learn more about Pfizer clinical trials, please click here.

Clinical Trials.gov

Search for actively recruiting studies that you may be able to participate in or learn about new treatments that are being considered.